ZHANG, NAN;ZHONG, RONG;SUZHOU MAIDIXIAN PHARMACEUTICAL INC.
发明人:
ZHANG, NAN,ZHONG, RONG
申请号：
EP10853917
公开号：
EP2589601A4
申请日:
2010.07.30
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The present invention discloses a compound of formula (I) and citrate thereof as type 5 phosphodiesterase inhibitor, a preparation method thereof, and a pharmaceutical composition including the compound of formula (I) and citrate thereof. The experimental results of the present invention prove that the compound of formula (I) and citrate thereof can inhibit activity of type 5 phosphodiesterase, and can be used for treating erectile dysfunction, inhibiting platelet aggregation and treating thrombosis, decreasing pulmonary hypertension and treating cardiovascular diseases, treating asthma and treating diabetes gastroparesis.
